Fig.4c indicated that CX3CR1+PBDCs increased the expression of IL-13Ra1 and MHCII following CAS+NP-OVA treatment, which mimics secondary allergen sensitization in human AD patients. This evidence concerns the gene IL13RA1 and Alzheimer disease.